Published in Diabetes on September 01, 2010
Opioid receptor blockade improves hypoglycemia-associated autonomic failure in type 1 diabetes mellitus. J Clin Endocrinol Metab (2011) 1.52
Elimination of hypoglycemia from the lives of people affected by diabetes. Diabetes (2011) 0.96
Defective counterregulation and hypoglycemia unawareness in diabetes: mechanisms and emerging treatments. Endocrinol Metab Clin North Am (2012) 0.93
Linagliptin-a novel dipeptidyl peptidase inhibitor for type 2 diabetes therapy. Clin Med Insights Endocrinol Diabetes (2012) 0.80
Regulation of peripheral metabolism by substrate partitioning in the brain. Endocrinol Metab Clin North Am (2013) 0.79
Role of the hypothalamus in mediating protective effects of dietary restriction during aging. Front Neuroendocrinol (2012) 0.79
Naltrexone for treatment of impaired awareness of hypoglycemia in type 1 diabetes: A randomized clinical trial. J Diabetes Complications (2015) 0.77
Opioid receptor blockade prevents exercise-associated autonomic failure in humans. Diabetes (2012) 0.77
Metabolic mystery: aging, obesity, diabetes, and the ventromedial hypothalamus. Trends Endocrinol Metab (2013) 0.76
Magnitude of exercise-induced β-endorphin response is associated with subsequent development of altered hypoglycemia counterregulation. J Clin Endocrinol Metab (2011) 0.76
Hypothalamic EphA5 facilitates counterregulatory responses: possible role for bidirectional signaling leading to bistability that enhances responsiveness to hypoglycemia. Diabetes (2013) 0.75
Challenges in Modelling Hypoglycaemia-Associated Autonomic Failure: A Review of Human and Animal Studies. Int J Endocrinol (2016) 0.75
Opioid Receptor Activation Impairs Hypoglycemic Counterregulation in Humans. Diabetes (2017) 0.75
International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev (2000) 6.30
UCP2 mediates ghrelin's action on NPY/AgRP neurons by lowering free radicals. Nature (2008) 3.91
Peroxisome proliferator-activated receptor alpha target genes. Cell Mol Life Sci (2004) 3.86
The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. J Biol Chem (2005) 3.51
Local ventromedial hypothalamus glucopenia triggers counterregulatory hormone release. Diabetes (1995) 2.30
Local ventromedial hypothalamus glucose perfusion blocks counterregulation during systemic hypoglycemia in awake rats. J Clin Invest (1997) 2.16
Ventromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycemia. J Clin Invest (1994) 2.09
Restoration of hypothalamic lipid sensing normalizes energy and glucose homeostasis in overfed rats. J Clin Invest (2006) 1.94
PPARalpha governs glycerol metabolism. J Clin Invest (2004) 1.79
Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease. J Clin Invest (2007) 1.74
Influence of insulin in the ventromedial hypothalamus on pancreatic glucagon secretion in vivo. Diabetes (2010) 1.26
Ventromedial hypothalamic glucokinase is an important mediator of the counterregulatory response to insulin-induced hypoglycemia. Diabetes (2008) 1.25
Counterregulatory deficits occur within 24 h of a single hypoglycemic episode in conscious, unrestrained, chronically cannulated mice. Am J Physiol Endocrinol Metab (2006) 1.21
Hypoglycemia-associated autonomic failure in diabetes. Am J Physiol Endocrinol Metab (2001) 1.20
Local lactate perfusion of the ventromedial hypothalamus suppresses hypoglycemic counterregulation. Diabetes (2003) 1.17
Recurrent antecedent hypoglycemia alters neuronal oxidative metabolism in vivo. Diabetes (2009) 1.16
Proteomic analysis of beta-catenin activation in mouse liver by DIGE analysis identifies glucose metabolism as a new target of the Wnt pathway. Proteomics (2009) 1.14
Phosphatidylinositol 3-Akt-kinase-dependent phosphorylation of p21(Waf1/Cip1) as a novel mechanism of neuroprotection by glucocorticoids. J Neurosci (2007) 1.12
Chronic hypoglycemia and diabetes impair counterregulation induced by localized 2-deoxy-glucose perfusion of the ventromedial hypothalamus in rats. Diabetes (1999) 1.08
Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer. Breast Cancer Res Treat (2009) 1.08
Peroxisome proliferator-activated receptor-alpha-null mice have increased white adipose tissue glucose utilization, GLUT4, and fat mass: Role in liver and brain. Endocrinology (2006) 1.08
Substantial rise of plasma beta-endorphin levels after insulin-induced hypoglycemia in human subjects. J Clin Endocrinol Metab (1979) 1.03
Glucocorticoid-deficient corticotropin-releasing hormone knockout mice maintain glucose requirements but not autonomic responses during repeated hypoglycemia. Am J Physiol Endocrinol Metab (2006) 1.02
Acute induction of gene expression in brain and liver by insulin-induced hypoglycemia. Diabetes (2005) 1.00
AT2 receptor-mediated vasodilatation is unmasked by AT1 receptor blockade in conscious SHR. Br J Pharmacol (2004) 0.99
Activity of angiotensin-converting enzyme and risk of severe hypoglycaemia in type 1 diabetes mellitus. Lancet (2001) 0.99
Estrogen blunts neuroendocrine and metabolic responses to hypoglycemia. Diabetes (2003) 0.98
Opiate blockade enhances hypoglycemic counterregulation in normal and insulin-dependent diabetic subjects. Am J Physiol (1991) 0.96
CXCL14 and insulin action. Vitam Horm (2009) 0.96
Mu opioid receptor antagonists: recent developments. ChemMedChem (2007) 0.95
Secrets of the lac operon. Glucose hysteresis as a mechanism in dietary restriction, aging and disease. Interdiscip Top Gerontol (2007) 0.93
Hypoglycemia-associated autonomic failure is prevented by opioid receptor blockade. J Clin Endocrinol Metab (2009) 0.92
AT1 and AT2 receptor blockade and epinephrine release during insulin-induced hypoglycemia. Hypertension (1998) 0.89
Prediction of severe hypoglycaemia by angiotensin-converting enzyme activity and genotype in type 1 diabetes. Diabetologia (2002) 0.89
Losartan attenuates symptomatic and hormonal responses to hypoglycemia in humans. Clin Pharmacol Ther (2001) 0.87
Beta-endorphin inhibits hypoglycemia-induced gene expression of corticotropin-releasing factor in the rat hypothalamus. Endocrinology (1992) 0.84
Modulation of hypoglycemia-induced increases in plasma epinephrine by estrogen in the female rat. J Neurosci Res (2005) 0.84
Impact of recent antecedent hypoglycemia on hypoglycemic cognitive dysfunction in nondiabetic humans. Diabetes (1996) 0.82
Effect of caffeine on the recognition of and responses to hypoglycemia in humans. Ann Intern Med (1993) 0.80
Estradiol impairs hypothalamic molecular responses to hypoglycemia. Brain Res (2009) 0.77
ANG II increases 2-deoxyglucose uptake in mouse embryonic stem cells. Life Sci (2005) 0.77
The influence of captopril on the epinephrine response to insulin-induced hypoglycemia in humans. The interaction between the renin-angiotensin system and the sympathetic nervous system. Am J Hypertens (1992) 0.76
Peroxisome proliferation-associated control of reactive oxygen species sets melanocortin tone and feeding in diet-induced obesity. Nat Med (2011) 3.09
Silencing of estrogen receptor alpha in the ventromedial nucleus of hypothalamus leads to metabolic syndrome. Proc Natl Acad Sci U S A (2007) 2.59
Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease. FASEB J (2004) 2.56
Reducing hypothalamic AGRP by RNA interference increases metabolic rate and decreases body weight without influencing food intake. BMC Neurosci (2002) 1.44
VGF ablation blocks the development of hyperinsulinemia and hyperglycemia in several mouse models of obesity. Endocrinology (2005) 1.15
Transgenic neuronal expression of proopiomelanocortin attenuates hyperphagic response to fasting and reverses metabolic impairments in leptin-deficient obese mice. Diabetes (2003) 1.12
Central pro-opiomelanocortin gene delivery results in hypophagia, reduced visceral adiposity, and improved insulin sensitivity in genetically obese Zucker rats. Diabetes (2003) 1.11
Role of CBP and SATB-1 in aging, dietary restriction, and insulin-like signaling. PLoS Biol (2009) 1.10
SOD isoforms play no role in lifespan in ad lib or dietary restricted conditions, but mutational inactivation of SOD-1 reduces life extension by cold. Mech Ageing Dev (2008) 1.05
Metabolic pathways that mediate inhibition of hypothalamic neurons by glucose. Diabetes (2004) 1.04
Hypothalamic responses to fasting indicate metabolic reprogramming away from glycolysis toward lipid oxidation. Endocrinology (2010) 1.03
Role of glucocorticoids in mediating effects of fasting and diabetes on hypothalamic gene expression. BMC Physiol (2003) 1.00
Acute induction of gene expression in brain and liver by insulin-induced hypoglycemia. Diabetes (2005) 1.00
Reversal of diabetic nephropathy by a ketogenic diet. PLoS One (2011) 0.96
Adiponectin is stimulated by adrenalectomy in ob/ob mice and is highly correlated with resistin mRNA. Am J Physiol Endocrinol Metab (2002) 0.94
Secrets of the lac operon. Glucose hysteresis as a mechanism in dietary restriction, aging and disease. Interdiscip Top Gerontol (2007) 0.93
Block the FAS, lose the fat. Nat Med (2002) 0.92
Validated genomic approach to study differentially expressed genes in complex tissues. Neurochem Res (2002) 0.91
Inhibition of agouti-related peptide expression by glucose in a clonal hypothalamic neuronal cell line is mediated by glycolysis, not oxidative phosphorylation. Endocrinology (2007) 0.89
Evidence for only two independent pathways for decreasing senescence in Caenorhabditis elegans. Age (Dordr) (2009) 0.89
Adrenalectomy stimulates hypothalamic proopiomelanocortin expression but does not correct diet-induced obesity. BMC Physiol (2003) 0.87
The fatty acid synthase inhibitor cerulenin and feeding, like leptin, activate hypothalamic pro-opiomelanocortin (POMC) neurons. Brain Res (2003) 0.87
Characterization of the peroxisome proliferator activated receptor coactivator 1 alpha (PGC 1alpha) expression in the murine brain. Brain Res (2003) 0.85
Glucokinase regulates reproductive function, glucocorticoid secretion, food intake, and hypothalamic gene expression. Endocrinology (2007) 0.83
Chemosensory and caloric mechanisms influence distinct components of mortality rate. Exp Gerontol (2008) 0.82
Lifespan is not determined by metabolic rate: evidence from fishes and C. elegans. Exp Gerontol (2004) 0.82
Hypothalamic Fkbp51 is induced by fasting, and elevated hypothalamic expression promotes obese phenotypes. Am J Physiol Endocrinol Metab (2012) 0.81
Regulation of peripheral metabolism by substrate partitioning in the brain. Endocrinol Metab Clin North Am (2013) 0.79
Role of the hypothalamus in mediating protective effects of dietary restriction during aging. Front Neuroendocrinol (2012) 0.79
Hypothalamic BDNF and obesity: found in translation. Nat Med (2012) 0.78
Glucose-induced metabolic memory in Schwann cells: prevention by PPAR agonists. Endocrinology (2013) 0.78
Estradiol impairs hypothalamic molecular responses to hypoglycemia. Brain Res (2009) 0.77
Specific preservation of biosynthetic responses to insulin in adipose tissue may contribute to hyperleptinemia in insulin-resistant obese mice. J Nutr (2004) 0.77
Comparative proteomic analysis of the ATP-sensitive K+ channel complex in different tissue types. Proteomics (2013) 0.76
Fasting Regulates Hypothalamic Neuropeptide Y, Agouti-Related Peptide, and Proopiomelanocortin in Diabetic Mice Independent of Changes in Leptin or Insulin1. Endocrinology (1999) 0.75
Corrigendum: Synchronized age-related gene expression changes across multiple tissues in human and the link to complex diseases. Sci Rep (2016) 0.75
The physiological function of the agouti-related peptide gene: the control of weight and metabolic rate. Ann Med (2003) 0.75